传染病学传染病学 (10).pdf
《传染病学传染病学 (10).pdf》由会员分享,可在线阅读,更多相关《传染病学传染病学 (10).pdf(17页珍藏版)》请在淘文阁 - 分享文档赚钱的网站上搜索。
1、116STEATOHEPATITIS/METABOLIC LIVER DISEASE|Hepatology,Vol.74,No.1,2021 Myeloid-Cell Specific IL-6 Signaling Promotes MicroRNA-223-Enriched Exosome Production to Attenuate NAFLD-Associated FibrosisXin Hou,1,2*Shi Yin,2,3*,#Ruixue Ren,4,5 Siqi Liu,1 Liang Yong,1 Yuxiao Liu,6 Yu Li,6 Ming-Hua Zheng,7 G
2、eorge Kunos,8 Bin Gao,2 and Hua Wang4,5SEE EDITORIAL ON PAGE 5BaCKgRoUND aNDS aIMS:NAFLD is associated with elevation of many cytokines,particularly IL-6;however,the role of IL-6 in NAFLD remains obscure.The aim of this study was to examine how myeloid-specific IL-6 signaling af-fects NAFLD by the r
3、egulation of antifibrotic microRNA-223(miR-223)in myeloid cells.appRoaCH aND ReSUltS:Patients with NAFLD or NASH and healthy controls were recruited,and serum IL-6 and soluble IL-6 receptor (sIL-6R)were measured.Compared to controls,serum IL-6 and sIL-6R levels were elevated in NAFLD/NASH patients.I
4、L-6 levels correlated positively with the number of circulating leukocytes and monocytes.The role of IL-6 in NAFLD was investigated in Il6 knockout(KO)and Il6 receptor A(Il6ra)conditional KO mice after high-fat diet(HFD)feeding.HFD-fed Il6 KO mice had worse liver injury and fibrosis,but less inflamm
5、ation,compared to wild-type mice.Hepatocyte-specific Il6ra KO mice had more steatosis and liver injury,whereas myeloid-specific Il6ra KO mice had a lower number of hepatic infiltrating macrophages(IMs)and neutro-phils with increased cell death of these cells,but greater liver fibrosis(LF),than WT mi
6、ce.Mechanistically,the increased LF in HFD-fed,myeloid-specific Il6ra KO mice was attributable to the reduction of antifibrotic miR-223 and subsequent up-regulation of the miR-223 target gene,transcriptional activa-tor with PDZ-binding motif(TAZ),a well-known factor to promote NASH fibrosis.In vitro
7、,IL-6 treatment up-regulated exosome biogenesis-related genes and subsequently promoted macrophages to release miR-223-enriched exosomes that were able to reduce profibrotic TAZ expression in hepatocytes by exosomal transfer.Finally,serum IL-6 and miR-223 levels were elevated and correlated with eac
8、h other in NAFLD patients.CoNClUSIoNS:Myeloid-specific IL-6 signaling inhibits LF through exosomal transfer of antifibrotic miR-223 into hepatocytes,providing therapeutic targets for NAFLD therapy.(Hepatology 2021;74:116-132).NAFLD is the most prominent cause of chronic hepatic disease worldwide.(1,
9、2)It rep-resents a spectrum of disorders that ranges from simple steatosis to NASH,cirrhosis,and HCC.(3)Inflammation is generally believed to play a key role in the progression of NAFLD.(3-5)However,the exact effects of inflammation on NAFLD progression,especially on liver fibrosis(LF),remain obscur
10、e.(4,5)Abbreviations:Acc1,acetyl-coenzyme A carboxylase;ALIX,ALG-2-interacting protein X;ALT,alanine aminotransferase;AST,aspartate aminotransferase;BSA,bovine serum albumin;CLEC-4F,C-type lectin domain family 4 member F;Col1a1,collagen type I alpha 1 chain;Ctgf,connective tissue growth factor;CXCL1
11、0,C-X-C motif chemokine 10;ESCRT,endosomal sorting complexrequired for transport;gp130,glycoprotein 130;HC,healthy control;HFD,high-fat diet;IBA-1,ionized calcium-binding adaptor molecule 1;Ihh,Indian hedgehog;Il6ra,Il6 receptor A;IL-6R,IL-6 receptor;IL6raHep/,hepatocyte-specific Il6ra KO;Il6raMye/,
12、myeloid-specific Il6ra KO;IMs,infiltrating macrophages;ISH,in situ hybridization;KCs,Kupffer cells;KO,knockout;LF,liver fibrosis;Ly6g,lymphocyte antigen 6 complex locus G6D;MCP1,monocyte chemoattractant protein 1;Mip,macrophage inflammatory protein;miR-223,microRNA-223;MMPs,matrix-degrading metallop
13、roteinase enzymes;MPO,myeloperoxidase;MVBs,multivesicular bodies;NLRP3,NOD-,LRR-,and pyrin domain-containing protein 3;nsmase2,neutral sphingomyelinase 2;NTA,nanoparticle tracking analysis;PA,palmitic acid;Pdgf,platelet-derived growth factor;PPAR,peroxisome proliferator-activated receptor alpha;-sma
14、,alpha-smooth muscle actin;Stam1,signal-transducing adapter molecule 1;STAT3,signal transducer and activator of transcription 3;TAZ,transcriptional activator with PDZ-binding motif;Timp,tissue inhibitor of metalloproteinase;Tsg101,tumor susceptibility gene 101;WT,wild type.Received June 9,2020;accep
15、ted October 29,2020.Additional Supporting Information may be found at AL.117IL-6 is a pleiotropic cytokine with complex roles in inflammation,playing important roles in controlling the pathogenesis of all types of diseases,includ-ing NAFLD.(6-11)Elevated serum,hepatic,and adi-pose IL-6 levels in pat
16、ients with NASH have been implicated in insulin resistance,steatosis,and liver injury.(6-12)IL-6 levels are also elevated in mice fed a high-fat diet(HFD),and genetic deletion of Il6 enhanced HFD-induced steatosis and liver injury.(13)In contrast,deletion of Il6 gene-attenuated liver injury and infl
17、ammation in another model of NASH that was induced by feeding the methionine and choline-deficient diet.(14)These contradictory data on the role of IL-6 in NAFLD were probably attributable to the different models used and widely expressed membrane-bound IL-6 receptor (mIL-6R)and its signaling chain,
18、glycoprotein 130(gp130),as well as the existence of soluble IL-6R(sIL-6R)and soluble gp130.(15)Gp130 is ubiquitously expressed,whereas IL-6 receptor (IL-6R)expression is restricted largely to hepatocytes,megakaryocytes,and subsets of leukocytes.(15)Myeloid cells,including macrophages and neutrophils
19、,express IL-6R and are key media-tors of obesity-associated inflammation.(15)Although macrophages have been implicated in the proinflam-matory phenotype in the early phase of NASH,they may adopt a restorative phenotype in the chronic res-olution phases of liver disease to limit LF.(16-18)The role of
20、 myeloid-specific IL-6 signaling in the control of NAFLD progression remains unknown.IL-6 activates classic signaling through the binding of mIL-6R,resulting in gp130 dimerization and sub-sequent activation of Janus kinases and signal transducer and activator of transcription 3(STAT3).Activated STAT
21、3 leads to IL-6-dependent gene expression and cellular responses,such as acute phase response,prolif-eration,migration,or metabolic changes.(15)IL-6 can also signal through the soluble IL-6 receptor(sIL-6R)and gp130,which is known as trans-signaling and allows cells that do not express IL-6R to resp
22、ond to IL-6.(19)IL-6-mediated trans-signaling has been shown to play a role in a variety of liver functions,such as liver regeneration.(20)sIL-6R was previously consid-ered as a systemic buffer system by promoting IL-6*These authors contributed equally to this work.Supported,in part,by the National
23、Nature and Science Foundation of China grants(81770588 to H.W.)and by the intramural program of the NIAAA,NIH,USA(to B.G.).Dr.Xin Hou was supported by the First Affiliated Hospital of Anhui Medical University Training Foundation when she performed experiments of mouse models at the NIAAA during 2018
24、-2019.Shi Yin was a participant in the NIH Graduate Partnerships Program and a graduate student in the Anhui Medical University when she worked on this project during 2008-2011,and was affiliated with the Anhui Medical University and the NIH Graduate Partnerships Program.#Dr.Yin Shis current address
25、:Division of Life Sciences and Medicine,Department of Geriatrics,The First Affiliated Hospital,University of Science and Technology of China,Hefei,China.2020 by the American Association for the Study of Liver Diseases.View this article online at .DOI 10.1002/hep.31658Potential conflict of interest:N
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 传染病学传染病学 10 传染病 10
限制150内